Gal-3 typically promotes tumor progression and is linked to the development and malignancy of various cancers, including pancreatic cancer, hepatocellular carcinoma, renal cell carcinoma, esophageal squamous cell carcinoma, nasopharyngeal carcinoma, melanoma, glioblastoma, and lymphoma. Here, LGALS3 is linked to glioblastoma.